Invivyd (IVVD) Return on Capital Employed (2021 - 2025)
Invivyd (IVVD) posted Return on Capital Employed of 31.96% for Q4 2025, up 64.23% on a QoQ basis from 89.35% in Q3 2025, and up 17926.0% year-over-year from N/an in Q4 2024.
Invivyd (IVVD) Return on Capital Employed (2021 - 2025) Analysis & Trends
Invivyd's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 31.96% for Q4 2025.
- Quarterly Return on Capital Employed rose 17926.0% year-over-year to 31.96% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 31.96% (up 17926.0% YoY) and the FY2025 annual result came in at 32.87%, up 11783.0% from the prior year.
- Return on Capital Employed was 31.96% for Q4 2025 at Invivyd, up from 89.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 31.96% in Q4 2025 and bottomed at 257.32% in Q3 2024.
- A 5-year average of 109.97% and a median of 69.25% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed tumbled 18868 bps — and 2025, when it soared 17926 bps.
- Invivyd's Return on Capital Employed stood at 38.39% in 2021, then plunged by 71 bps to 65.46% in 2022, then sank by 61 bps to 105.45% in 2023, then slumped by 100 bps to 211.21% in 2024, then jumped by 85 bps to 31.96% in 2025.
- Business Quant data shows IVVD's Return on Capital Employed at 31.96% in Q4 2025, 89.35% in Q3 2025, and 218.35% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -68.84% |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -31.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.96% |
| Sep 30, 2025 | -89.35% |
| Jun 30, 2025 | -218.35% |
| Mar 31, 2025 | -220.35% |
| Dec 31, 2024 | -211.21% |
| Sep 30, 2024 | -257.32% |
| Jun 30, 2024 | -134.72% |
| Mar 31, 2024 | -118.17% |
| Dec 31, 2023 | -105.45% |
| Sep 30, 2023 | -68.64% |
| Jun 30, 2023 | -62.73% |
| Mar 31, 2023 | -54.05% |
| Dec 31, 2022 | -65.46% |
| Sep 30, 2022 | -69.25% |
| Jun 30, 2022 | -65.40% |
| Mar 31, 2022 | -58.65% |
| Dec 31, 2021 | -38.39% |